Medicine Recommendations

Type 2 diabetes

Treatment of severe hypoglycaemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus.

Gender Dysphoria

Acute Gout (as per LSCMMG Guidelines)

For replacement therapy of adrenal insufficiency in children and adolescents (from birth to <18 years old)

Treatment of congenital adrenal hyperplasia (CAH) in adolescents aged 12 years and over and adults.

Treatment of adrenal insufficiency in adults.

Treatment of post menopausal osteoporosis

MHRA Drug Safety Update - Bisphosphonates: very rare reports of osteonecrosis of the external auditory canal

MHRA Drug Safety Update - Bisphosphonates: atypical femoral fractures

Postmenopausal osteoporosis

MHRA Drug Safety Update - Bisphosphonates: very rare reports of osteonecrosis of the external auditory canal

MHRA Drug Safety Update - Bisphosphonates: atypical femoral fractures

adjuvant treatment of early breast cancer in postmenopausal women with a high risk of recurrence (unlicensed indication)

Type 1 and type 2 diabetes mellitus

For the treatment of diabetes mellitus type 1 and 2 in adults

Type 2 diabetes

Type 1 diabetes

Treatment of adults with type 2 diabetes mellitus (T2DM) to improve glycaemic control, in combination with oral glucose-lowering medicinal products when these alone, or combined with basal insulin, do not provide adequate glycaemic control

Treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above

Type 1 and Type 2 diabetes mellitus

For biosimilars see Insulin glargine biosimilar (Abasaglar®)

Type 1 and Type 2 diabetes mellitus

Treatment of diabetes

Type 1 diabetes mellitus